Physician profile
Patrick J Simpson
NPI 1841234887
$579,343.76
in general payments reported to CMS, 2019-2025
66 companies · $51K in 2025
The $51K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175K · 2020: $81K · 2021: $62K · 2022: $50K · 2023: $76K · 2024: $85K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $184K · Travel and Lodging: $16K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $184,043.75 |
| Travel and Lodging | $15,788.11 |
| Food and Beverage | $11,780.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $173,968.14 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $160,005.75 | 2019-2025 | Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $59,598.24 | 2019-2025 | |
| Boston Scientific Corporation | $51,454.78 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Astrazeneca Pharmaceuticals Lp | $48,334.27 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Sanofi-Aventis U.S. LLC | $36,586.19 | 2019-2024 | |
| Esperion Therapeutics, INC. | $23,498.42 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $10,456.30 | 2019 | |
| Merck Sharp & Dohme LLC | $3,193.62 | 2022-2024 | Verquvo |
| Abbott Laboratories | $1,426.47 | 2019-2025 | Coroflow, Cardiomems, Amplatzer Amulet |
| Novo Nordisk INC | $1,334.02 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Abiomed | $959.36 | 2019-2025 | Impella |
| Preventric Diagnostics, INC. | $934.82 | 2022 | |
| Medtronic, INC. | $922.56 | 2022-2025 | Symplicity G3, In.Pact Av, Cobalt Dr Mri Surescan |
| Amgen INC. | $639.29 | 2019-2025 | Repatha, Repatha |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $614.15 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $480.99 | 2019-2024 | Xarelto |
| Pfizer INC. | $479.74 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $467.73 | 2019-2025 | Lifevest |
| Scpharmaceuticals INC. | $392.91 | 2023-2024 | |
| Shockwave Medical, INC | $377.32 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $286.56 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $278.24 | 2019-2024 | Uptravi, Opsumit |
| Philips North America LLC | $254.62 | 2019-2025 | Coronary Other |
| Cardiovascular Systems INC. | $253.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $207.29 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $205.11 | 2019-2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $185.80 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $167.76 | 2025 | Attruby |
| Medtronic Vascular, INC. | $130.56 | 2019 | |
| Opsens INC. | $117.33 | 2019 | |
| W. L. Gore & Associates, INC. | $90.87 | 2019-2021 | |
| Chiesi USA, INC. | $90.45 | 2022-2023 | Kengreal |
| Atricure, INC. | $84.76 | 2020-2024 | |
| Lexicon Pharmaceuticals, INC. | $82.35 | 2023-2024 | Inpefa |
| Cordis US Corp. | $61.10 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Lundbeck LLC | $57.67 | 2019-2020 | |
| Daiichi Sankyo INC. | $55.58 | 2022-2023 | Injectafer |
| Amarin Pharma, INC. | $51.41 | 2019-2023 | |
| Braemar Manufacturing, LLC | $46.15 | 2019 | |
| Janssen Scientific Affairs, LLC | $38.09 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals, Ltd. | $37.52 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $35.68 | 2022-2024 | Sapien 3 Ultra Resilia |
| Kestra Medical Technology Services, INC. | $34.19 | 2024 | Assure Wcd |
| Teleflex LLC | $34.11 | 2024-2025 | Vascband, Trapliner |
| Celgene Corporation | $33.61 | 2024 | Camzyos |
| Irhythm Technologies, INC. | $33.31 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Glaxosmithkline, LLC. | $29.75 | 2025 | Arexvy, Shingrix |
| Biomerieux INC | $28.43 | 2019 | |
| Angiodynamics, INC. | $24.16 | 2025 | Alphavac |
| Cardinal Health 200 LLC | $22.41 | 2019 | |
| Gilead Sciences, INC. | $22.11 | 2019 | |
| Terumo Medical Corporation | $18.34 | 2025 | Metacross Otw, Angio-Seal |
| Akcea Therapeutics, INC. | $18.21 | 2019 | |
| Stryker Corporation | $17.61 | 2025 | Flowtriever |
| Cardiva Medical, INC. | $15.85 | 2025 | Optowire |
| Inspire Medical Systems, INC. | $15.82 | 2024 | Inspire |
| Arbor Pharmaceuticals, INC. | $15.64 | 2019 | |
| Biotronik INC. | $14.34 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.84 | 2019 | |
| B. Braun Interventional Systems INC. | $10.81 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.